EXTEND is being conducted by the Immune Tolerance Network and TrialNet and is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (NIH funded).